Search
Spotlight
Coronavirus
Influenza
Clinical
Allergy
Cardiology
Diabetes
Gastroenterology
Geriatric Medicine
Infectious Disease
Neurology
Psychiatry
Pulmonology
Rheumatology
Video Series
Insights
News Network
Peer Exchange
Peers & Perspectives
Post Conference Perspectives
Media
Medical World News
News Articles
Podcasts
Videos
Webinars
Conferences
Conference Coverage
Conference Listing
Partners
Resources
Education
Exclusive Content
Interactive Tools
Live Events
Physician's Money Digest
Press Release
Publications
Sponsored
Subscribe
Search
Spotlight
Coronavirus
Influenza
Clinical
See All >
Allergy
Cardiology
Diabetes
Gastroenterology
Geriatric Medicine
Infectious Disease
Neurology
Psychiatry
Pulmonology
Rheumatology
Video Series
Insights
News Network
Peer Exchange
Peers & Perspectives
Post Conference Perspectives
Biologic Treatment Considerations for Asthma During the COVID-19 Pandemic and the Upcoming Flu Season
EP 1: Overview of Uncontrolled Asthmatic Episode
EP 2: Quality of Life and Increased Risk of Asthma Exacerbations
EP 3: Over and Under Diagnosis of Asthma
EP 4: Targeted Pathology for the Treatment of Asthma
EP 5: Common Biomarkers of Asthma to Determine Treatment Efficacy
EP 6: Raising Awareness Among Physicians Regarding Biologics
EP 7: FDA Approved Agent Omalizumab for Asthma
EP 8: Patient Factors That Determine the Use of Omalizumab in Asthma
EP 9: IL-5 Inhibitors for Treatment of Asthma
EP 10: Dupilumab for Moderate to Severe Asthma
EP 11: Safety Profile of Biologics When Treating Asthma
EP 12: Managing Asthma During COVID-19
EP 13: Precautions Taken to Control Asthma During COVID-19
EP 14: Anxiety Among Patients With Asthma During COVID-19
EP 15: Importance of Flu Shots for Patients With Asthma During COVID-19
Next >>
x